Delivery Order FA853313D0001-0001

The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services (HHS), has awarded a Cost Plus Fixed Fee delivery order contract worth $302,586 to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp., for the Gene Therapy Resource Program (GTRP) - Clinical Coordinating Center. The contract is for Task Area A: Core Administrative Activities and has an ultimate completion date of July 31, 2024. This contract award is...

This purchase order, awarded by the National Institutes of Health's National Institute of Child Health and Human Development, is for one unit of HAPLOGEN HAP1DEPDC52039600 CRISPR/CAS9-EDITED DEPDC5 for $1,105.90, with a total contract value of $5,728.50. The prime contractor, Government Scientific Source Inc. doing business as G S S, will deliver the product from its place of performance in Herndon, Virginia between September 11, 2014 and October 31, 2014 under firm fixed pricing. No set aside...

This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp. The $2,800,040 award is for Task Order 5 under the Gene Therapy Resource Program (GTRP) Clinical Coordinating Center, specifically for Task Area B related to clinical trials in fiscal year 2015. The contract is a cost-plus-fixed-fee type and does not have a set-aside...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $3,037,751.63 cost-plus-fixed-fee delivery order contract to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp. The contract is for the Gene Therapy Resource Program (GTRP), which supports translational gene therapy research by providing resources and services from three core laboratories: a Pharmacology and Toxicology Core Laboratory, a Preclinical Vector Core Laboratory, and a Clinical Coordinating Center....

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $1,292,182, is for the development of a haptoglobin treatment to reduce complications of sickle cell disease. The contract is a definitive, firm-fixed-price contract with a period of performance ending on June...

The National Institutes of Health's National Heart, Lung and Blood Institute awarded a firm fixed price purchase order valued at $199,999.90 to the Sanford Burnham Prebys Medical Discovery Institute. The contract calls for the prime contractor to provide functional glycan profile screening of UDP patients to determine the pathogenicity of genetic variants analysis, as requested in the December 4, 2018 presolicitation notice. Screening will take place at the contractor's location in La Jolla,...

Government Scientific Source Inc., doing business as G S S, has been awarded a $57,161.60 firm fixed price delivery order against its Multiple Award Schedule contract with the General Services Administration. The order, placed by the National Heart, Lung and Blood Institute within the Department of Health and Human Services, is to provide single cell genomics kits to support the Laboratory of Immune Regulatory Genomics and Epigenomics in optimizing chimeric antigen receptor T cells....

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price Delivery Order to Government Scientific Source Inc. (GSS) on November 30, 2018 to provide an Ion GS S5 and Ion Chef System for the DNA Sequencing Core used by National Heart, Lung, and Blood Institute (NHLBI) principal investigators, staff, and fellows. The contract has a potential value of $119,000.00 and is not associated with a set-aside. GSS is a...

This is a firm-fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to PGI Holding Corporation, a for-profit subchapter S corporation. The contract, valued at $139,400.00, is for the engraftment of human induced pluripotent stem cell (iPSC) derived astrocytes into the forebrain of adult and neonatal wild type mice. The contract was awarded on a non-competitive basis under simplified acquisition...

The National Institute of Dental and Craniofacial Research, a civilian agency within the Department of Health and Human Services, awarded a $26,250.00 firm fixed price purchase order to the New York Stem Cell Foundation Inc., a non-profit organization, to provide 3 patient-derived induced pluripotent stem cell (iPSC) lines with isogenic controls for the study of DiGeorge Syndrome (DGS). This contract was awarded under a broader solicitation seeking DGS patient-derived iPSCs to generate neural...